Also know that the Charge players were not in the least discouraged by their four-overtime loss on Mother’s Day — the mood in the room afterward was described as “super positive.” ...

Atlanta News First A Georgia man is now facing murder charges as prosecutors and loved ones claim he intentionally did not disclose his HIV-positive status to his wife, a cancer survivor.

"At any time, he could have told her and given her the right to make the decision to stay with him," Denise's daughter said A Georgia man is now facing murder charges as prosecutors and loved ones ...

The market churn, consequent to Trump’s reciprocal tariffs and the tariff war that followed, has left investors scrambling to find safe investment options. No asset class or no sector has been ...

MANILA, Philippines — The House Quad Committee’s recommendation to file criminal raps against former President Rodrigo Duterte and other drug war officials is a “positive step” in seeking ...

Sebi has mandated that the new charge structure should lead to a reduction in costs for end clients, ensuring a fair and transparent market ecosystem. MIIs, acting as first-level regulators ...

Ph.D., Founder and CEO of Structure. “We designed GSBR-1290 to be dosed once-a-day, and are pleased to see the competitive treatment effect at 12 weeks, dose proportional exposure and target ...

This includes a new reduced commission structure. iOS apps in the EU can ... applies per install … The Core Technology Fee (CTF) charges €0.50 per annual install, for apps that are popular ...

In this study, we investigated the interactions of peptide coacervates composed of HBpep—peptide derived from the histidine-rich beak proteins ... At pH 6, when the peptide carries a net positive ...

Federal government has charged online publishers to promote positive reports on Nigeria on social media, saying it is crucial to the socio-economic growth and development of the country.

Structure Therapeutics Inc shares surged 34% to $50.34 in midday trading on Friday after the clinical-stage global biopharmaceutical company announced what it called positive results of the Phase 1b ...

“These positive Phase 1b results support GSBR-1290 as a promising, differentiated oral GLP-1 receptor agonist with once-daily dosing,” said Raymond Stevens, Ph.D., Founder and CEO of Structure.